PROFUSA Price to Free Cash Flow Ratio 2022-2021 | PFSA
Historical price to free cash flow ratio values for PROFUSA (PFSA) since 2022.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| PROFUSA Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-08-01 | 0.59 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.000B |
| Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.442B | 59.08 |
| Hims & Hers Health (HIMS) | United States | $14.813B | 153.91 |
| Doximity (DOCS) | United States | $11.035B | 51.09 |
| Tempus AI (TEM) | United States | $9.797B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.673B | 57.39 |
| Hinge Health (HNGE) | United States | $3.507B | 0.00 |
| Privia Health (PRVA) | United States | $2.380B | 162.67 |
| 10x Genomics (TXG) | United States | $1.656B | 0.00 |
| Phreesia (PHR) | United States | $1.604B | 0.00 |
| Enovis (ENOV) | United States | $1.531B | 8.53 |
| Azenta (AZTA) | United States | $1.497B | 69.57 |
| Schrodinger (SDGR) | United States | $1.492B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.453B | 27.44 |
| Evolent Health (EVH) | United States | $1.180B | 100.50 |
| Claritev (CTEV) | United States | $0.655B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.505B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.423B | 0.00 |
| Talkspace (TALK) | United States | $0.407B | 121.50 |
| TruBridge (TBRG) | United States | $0.313B | 694.00 |
| Outset Medical (OM) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.179B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.113B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.074B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |